本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPYRE THERAPEUTICS INC

89.33
-1.0300-1.14%
盘后89.330.00000.00%19:30 EDT
成交量:191.32万
成交额:1.70亿
市值:78.77亿
市盈率:-44.44
高:90.97
开:89.15
低:86.40
收:90.36
52周最高:110.18
52周最低:14.51
股本:8,817.38万
流通股本:8,097.70万
量比:1.35
换手率:2.36%
股息:- -
股息率:- -
每股收益(TTM):-2.0100
每股收益(LYR):-1.9755
净资产收益率:-22.98%
总资产收益率:-19.81%
市净率:8.25
市盈率(LYR):-45.22

数据加载中...

2026/08/26

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities